Fulcrum Therapeutics, Inc.·4

Apr 2, 4:30 PM ET

Dunn Judith 4

4 · Fulcrum Therapeutics, Inc. · Filed Apr 2, 2021

Insider Transaction Report

Form 4
Period: 2021-04-01
Dunn Judith
See Remarks
Transactions
  • Award

    Stock Option (right to buy)

    2021-04-01+215,000215,000 total
    Exercise: $12.00Exp: 2031-03-31Common Stock (215,000 underlying)
Footnotes (1)
  • [F1]This option was granted on April 1, 2021 and is scheduled to vest 25% on the first anniversary of the vesting commencement date of April 1, 2021. The remainder of the shares underlying the grant shall vest in equal quarterly installments over the following three years until the fourth anniversary of the vesting commencement date, subject to continued service.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION